Drug Device Combination Market 2022 Emerging Trends
Drug
Device Combination is combining two or more different types of products
including medical devices, biologics and drugs. With drug device combination
products there is an increase in overall efficacy and percentage of patients
who respond. The efficacy depends upon the pharmacodynamics and pharmacokinetic
properties of the drug used in combination. There are different types of drug
device combination products. In case of infusion pumps, fluids such as
nutrients and medications are administered into a patient’s body in controlled
amounts. Next drug device combination product is inhaler which helps in
administering drug to a patient via lungs. Further, transdermal patch is an
adhesive pad which is placed on skin to administer a time released dose of
medication directly into the bloodstream via skin. In case of drug eluting
stents such as urethral stents, the stent is coated with medicines such as
heparin which is an anti-coagulating agent. This stent maintains the urinary
flow from the kidney to the bladder while avoiding coagulation. Another drug
device combination product is orthopedic drug combination product such as
antibiotic bone cement which is used for treating infected joint
arthroplasties. Next combination product is drug device combination, in which
duration of action of a drug and intensity is increased. It reduces the dosage
frequency and improves patient compliance. Wound care products are used in
managing wounds. In case of photodynamic therapy devices, a photosensitizer and
a type of light is used to treat tumors on the skin.
Ask for Customizations: https://www.crystalmarketresearch.com/report/drug-device-combination-market#customization
The major factor driving the growth of drug devices market
is increase in the prevalence of chronic diseases. According to European
Academy of Allergy and Clinical Immunology (EAACI), in 2013, around 300 million
people were suffering from asthma and the number is expected to increase by 100
million by 2025. In terms of global years lived with disability, the Global
Asthma Network states that asthma is the 14TH most
important medical condition worldwide. Further, it also states that, asthmatic
symptoms are experienced by 14% of the total children population across the
world. Additionally, increase in the adoption of point of care treatments will
also boost this market. Moreover, increase in the geriatric population will
also drive this market. For instance, according to WHO, in 2015, 900
million people were 60 years of age or older and the number is expected to
reach up to 2 billion by 2050.
The key strategy followed by the major players in the drug
device combination market is product launch to gain competitive advantage and
more market share. For instance, in 2016, AstraZeneca’s Bevespi Aerosphere was
approved by the FDA for patients with COPD. It is a metered dose inhaler which
contains combination of two drugs, namely, glycopyrrolate and formoterol
fumarate. With the launch of this drug AstraZeneca will gain competitive
advantage and more share in the market.
Major Market Players
Ø
Medtronic
Ø
Terumo Corporation
Ø
W. L. Gore & Associates, Inc.
Ø
C.R. Bard, Inc.
Ø
Johnson & Johnson Private Limited
Ø
Stryker Corporation
Ø
Medline
Ø
Medtronic
Ø
Mylan Inc.
Ø
Becton
Ø
Dickinson Company
Ø Pinnacle
Biologics.
Drug
Device Combination Market Segmentation:
By
Product:
- Antimicrobial Catheters
o
Cardiovascular
o
Urological
o
Others
- Infusion Pumps
o
Insulin
o
Volumetric
o
Syringes
o
Implantable
o
Disposables
o
Ambulatory
- Inhalers
o
Metered Dose
o
Nebulizers
o
Dry powder
- Drug Eluting Stents
o
Peripheral Vascular
Stents
o
Coronary Stents
- Orthopedic Combination Products
o
Antibiotic Bone Cement
o
Bone Graft Implants
- Wound Care Products
- Transdermal Patches
- Photodynamic Therapy Devices
- Others
By
Region:
- North
America
o
U.S
o
Canada
o
Mexico
- Europe
o
Germany
o
France
o
UK
o
Italy
o
Spain
o
Rest of Europe
- Asia-Pacific
o
Japan
o
China
o
Australia
o
India
o
South Korea
o
Rest of Asia-Pacific
- Rest
of the World
o
Brazil
o
South Africa
o
Saudi Arabia
o
Turkey
o
United Arab Emirates
o
Others
About Us:
Crystal Market Research is a U.S. based
market research and business intelligence company. Crystal offers one stop
solution for market research, business intelligence, and consulting services to
help clients make more informed decisions. It provides both syndicated as well
as customized research studies for its customers spread across the globe. The
company offers market intelligence reports across a broad range of industries
including healthcare, chemicals & materials, technology, automotive, and
energy.
Contact
Us:
Judy
304 South Jones Blvd, Suite 1896,
Las Vegas NV 89107,
United States
Toll Free: +1-888-213-4282
304 South Jones Blvd, Suite 1896,
Las Vegas NV 89107,
United States
Toll Free: +1-888-213-4282
Website:
www.crystalmarketresearch.com
Comments
Post a Comment